Research and innovation news

IBM (NYSE: IBM) and researchers from the University of Chicago today announced a demonstration in quantum computing that achieves the fundamental criteria for quantum advantage: performing computations beyond the reach of leading classical simulation methods while providing trust that the computation returned accurate results.

Qedma Quantum Computing, a pioneer in quantum error reduction software and IBM (NYSE: IBM) today announced a breakthrough study demonstrating how trusted, error-mitigated quantum computation is possible, and can be used to explore the physics of materials beyond the capabilities of state-of-the-art classical simulations, including those run on one of the world's most powerful supercomputers. By combining Qedma’s advanced error mitigation software, QESEM, with IBM quantum computers, researchers observed complex and long-lived quantum dynamics in systems of up to 74 qubits. This enabled them to reach a paradigm where multiple state-of-the-art classical approaches failed to provide consistent, reliable answers.

Algorithmiq and IBM (NYSE: IBM) announced a major milestone in the development of quantum computing: a joint demonstration of quantum advantage with the simulation of a heterogeneous quantum material, achieved with a new framework that establishes trust in quantum computations when classical verification is unavailable.

IBM (NYSE: IBM) today announced it has signed a definitive agreement to acquire HRL Laboratories, LLC (HRL), a flagship research and development institution. HRL is a private company jointly owned by Boeing and General Motors. Both Boeing and GM will continue to partner with IBM on quantum applications and advanced technology development following the transaction.

A team of scientists from Oak Ridge National Laboratory (ORNL), Cleveland Clinic, and IBM (NYSE: IBM), have calculated nine molecular configurations of a promising material to produce fuel for fusion energy – the first-known instance of such computations on quantum computers.

IBM unveiled a major semiconductor breakthrough with the introduction of the world’s first sub-1 nanometer (nm) chip technology, featuring a revolutionary transistor architecture at the 0.7 nm, or 7 angstrom node.

IBM (NYSE: IBM) has announced plans to invest more than $10 billion in quantum computing over the next five years. The investment will span research and development, capital expenditure, manufacturing scaling, ecosystem partnerships, and M&A. Together, these areas are designed to accelerate IBM's quantum roadmap beyond delivering the world's first large-scale, fault-tolerant quantum computer in 2029, and advance quantum leadership anchored in the United States.

Today, IBM and the U.S. Department of Commerce (DoC) announced a Letter of Intent (LOI) to build an American quantum chip, foundry securing the nation’s global quantum leadership and fueling the country’s growing quantum ecosystem. The CHIPS incentive from the DoC will support the research and development efforts of a new IBM company: Anderon, which will be America's first pure-play quantum foundry. This initiative represents one of the most significant commitments by the U.S. Government to date in quantum R&D to position the United States to manufacture most of the world’s quantum wafers.

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world’s most powerful supercomputers to simulate protein complexes spanning up to 12,635 atoms. These are the largest-known simulations of biologically meaningful molecules performed with quantum hardware yet, and signal that quantum computers are maturing into useful scientific tools which can help solve fundamental problems in biology, chemistry, and life sciences.

Tune in live Tuesday, May 5 at 8:30 a.m. ET as IBM (NYSE: IBM) CEO Arvind Krishna opens IBM Think 2026 and explains how AI is becoming the defining force in business, what it takes to lead, and how quantum computing is emerging as the next frontier.